Public Company News
ASCO 2022 | Ascentage Pharma Releases for the First Time Results of its FAK/ALK/ROS1 inhibitor APG-2449 Demonstrating Safety and Efficacy in Patients with Advanced NSCLC
SUZHOU, China, and ROCKVILLE, MD, June 7, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it has released the results from its Phase I ...
2022-06-08 08:00
2167
EZGO Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
CHANGZHOU, China, June 7, 2022 /PRNewswire/ -- EZGO Technologies Ltd. (Nasdaq: EZGO) ("EZGO" or the "Company"), a leading short-distance transportation solutions provider inChina, today announced that the Company had received a notification letter datedJune 3, 2022 from the Listing Qualification...
2022-06-08 04:30
2727
The Puzzles & Survival x Discovery Channel World Oceans Day Themed Commercial is Now Live
GUANGZHOU, China, June 7, 2022 /PRNewswire/ -- In line with BLANCOZONE's solidarity with global efforts to protect the planet on which we live, Puzzles & Survival, a post-apocalyptic Match-3 mobile strategy game published by 37GAMES , is playing host to a timed event known as "Ocean Defense." The ...
2022-06-07 21:00
3485
PHASE II STUDY OF PAXALISIB IN BRAIN METASTASES ADVANCES TO EXPANSION STAGE IN BREAST CANCER BRAIN METASTASES COHORT
SYDNEY, June 7, 2022 Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that a phase II, genomically-guided study of multiple therapies in patients with brain metastases, led by the Alliance for Clinical Trials in Oncology (NC...
2022-06-07 19:00
2978
Telix to Present at Jefferies Healthcare Conference
MELBOURNE, Australia and INDIANAPOLIS, June 7, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR) advises t...
2022-06-07 19:00
2437
Jianpu Technology Inc. to Report First Quarter 2022 Financial Results on Tuesday, June 14, 2022
BEIJING, June 7, 2022 /PRNewswire/ -- Jianpu Technology Inc. ("Jianpu," or the "Company") (NYSE: JT), a leading independent open platform for the discovery and recommendation of financial products inChina, today announced that it will report its first quarter 2022 unaudited financial results, onJ...
2022-06-07 18:24
4240
Yuchai Establishes New Engine Service Joint Venture
SINGAPORE, June 7, 2022 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD)("China Yuchai" or the "Company") a leading manufacturer and distributor of engines for on- and off-road applications inChina through its main operating subsidiary, Guangxi Yuchai Machinery Company Limited ("GYM...
2022-06-07 18:00
2810
With LG SIGNATURE Timeless Beauty is Turned into Experience
LG Electronics ultra-premium home appliance brand, LG SIGNATURE, celebrates art and beauty in technology through the short filmHide and Seek, created by Francesca Molteni. The film will premiere during Milan Design Week, sealing the collaboration between LG SIGNATURE and Molteni&C – two brands ...
2022-06-07 17:00
2541
Hello Group Inc. Announces Unaudited Financial Results for the First Quarter of 2022
BEIJING, June 7, 2022 /PRNewswire/ -- Hello Group Inc. (NASDAQ: MOMO) ("Hello Group" or the "Company"), a leading mobile social and entertainment platform in China, today announced its unaudited financial results for the first quarter of 2022. First Quarter of 2022 Highlights * Net revenues...
2022-06-07 16:10
4677
ASCO 2022 | Ascentage Pharma Releases Updated Results Demonstrating the Therapeutic Potential of Alrizomadlin (APG-115) plus Pembrolizumab in Patients with Solid Tumors who Progressed on Immunotherapies
SUZHOU, China, and ROCKVILLE, Md., June 6, 2022 /PRNewswire/ -- scentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it has released the updated results from a Pha...
2022-06-07 11:30
2622
ASCO 2022 | The First Dataset of Olverembatinib (HQP1351) in Patients with GIST Demonstrates Therapeutic Potential with a Clinical Benefit Rate of 83.3%
SUZHOU, China, and ROCKVILLE, Md., June 6, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it has released the latest results from a Pha...
2022-06-07 11:28
2455
Tuya Smart to Present Smart Lighting Solutions at LightFair 2022
NEW YORK, June 6, 2022 /PRNewswire/ -- Tuya Smart (NYSE: TUYA), a leading IoT development platform service provider, this week announced it will participate in the LightFair 2022 Trade Show and Conference. Hosted inLas Vegas, LightFair 2022 will take placeJune 19-23, 2022 at the Las Vegas Convent...
2022-06-07 10:23
3168
iNtRON Completes GLP-TOX Studies of BAL200
* A novel drug candidate for anthrax received orphan drug designation (ODD) by the US FDA. BOSTON and SEOUL, Korea, June 6, 2022 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON" or "Company") announced today that the company has successfully completed the GLP toxicology studies of BAL200. The co...
2022-06-07 09:00
2585
TIAN RUIXIANG Holdings Ltd Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
BEIJING, June 6, 2022 /PRNewswire/ -- TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the "Company"), a China-based insurance broker conducting business through its variable interest entity inChina, announced today that the Company received a written notification (the "Notification") from the Nasdaq S...
2022-06-07 05:00
4413
MINISO Group to Hold Annual General Meeting on July 11, 2022
GUANGZHOU, China, June 6, 2022 /PRNewswire/ -- MINISO Group Holding Limited (NYSE: MNSO) ("MINISO", "MINISO Group" or the "Company"), a global retailer offering a variety of design-led lifestyle products, today announced that it has called an annual general meeting (the "AGM") of shareholders to ...
2022-06-07 04:05
2659
IND approval from the US FDA for Phase II SAR-Bombesin imaging trial in prostate cancer
Highlights * IND approval received for SAR-Bombesin product, enabling a Phase II "SABRE" imaging trial to detect prostate cancer in up to 50 PSMA-negative participants in the US * Approximately 20% of prostate cancer patients with biochemical recurrence (BCR) are PSMA-PET negative and theref...
2022-06-06 21:08
2926
ASTRUM-005: Henlius Released Phase 3 Study Results for the First-line Treatment of Small Cell Lung Cancer of Serplulimab at ASCO 2022
SHANGHAI, June 6, 2022 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that an international randomized phase 3 study (ASTRUM-005) of HANSIZHUANG (serplulimab), an anti-PD-1 mAb independently developed by Henlius, as first-line treatment for extensive-stage small-cell lung can...
2022-06-06 21:00
3063
Senhwa's Pindnarulex in Combination Study with Pfizer's Talazoparib for the Treatment of Prostate Cancer Granted Approval to Initiate from Australian HREC
TAIPEI and SAN DIEGO, June 6, 2022 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, announced that it has received written approval from the Human Research Ethics Committ...
2022-06-06 21:00
3006
CARsgen Therapeutics Presents Updated Data for CT041 Claudin18.2 CAR T-cells in Solid Tumors at ASCO 2022
SHANGHAI, June 6, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that at the 2022 American Society of Clinical Oncology (ASCO) Annual M...
2022-06-06 20:50
3661
Cango Inc. to Report First Quarter 2022 Financial Results on June 9, 2022 Eastern Time
SHANGHAI, June 6, 2022 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), a leading automotive transaction service platform inChina, today announced that it plans to release its first quarter 2022 financial results after the market closes onThursday, June 9, 2022. The earnings re...
2022-06-06 20:00
2405
Week's Top Stories
Most Reposted
Vietnam Explores Sustainable Aviation Fuel Development at International Conference in Hanoi
[Picked up by 301 media titles]
2026-06-25 14:33
MetaOptics Begins Shipment of Metalens Smartphone and AI Smart Glasses to European and Japanese Customers for Evaluation
[Picked up by 299 media titles]
2026-06-26 18:11IPD and ABB Help Power Sustainable Operations at New Sydney Fish Market
[Picked up by 298 media titles]
2026-06-22 17:40
SPHERE AX Partners with U.S. AI Semiconductor Company Blaize at the National Assembly
[Picked up by 293 media titles]
2026-06-24 18:00
BELLUSTAR TOKYO Ranked No. 10 Among Japan's Best City Hotels in Prestigious Award Chosen by Asia-Pacific Travelers
[Picked up by 290 media titles]
2026-06-24 12:00
Most Read
/C O R R E C T I O N -- 707Livescore/
2026-06-20 18:39
5227
Indonesia's Supreme Court Urges Lawyers to Uphold Reason, Instinct, and Conscience Amid Growing Legal Complexity
2026-06-20 01:37
5045
Hong Kong Brings the PUMA HYROX World Championships to the APAC Region for the First Time in 2027
2026-06-20 08:00
4644
Felicitysolar Strengthens Brand Presence at SNEC 2026
2026-06-20 10:44
4368
